Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s Opportunity
This Continuing Education activity is supported by an educational grant from Sandoz Inc.
This activity is supported by an educational grant from Sandoz Inc.
Jeffrey D. Dunn, PharmD, MBACCO/SVPVRx, LLCVP MagellanRxSalt Lake City, UtahDouglas S. Burgoyne, PharmD,FAMCPSVP & Market GM MagellanRxSalt Lake City, Utah
Jessica MartinMartin Medical Writing, LLCSaint Paul, Minnesota
After completing this continuing education program, the participant will be able to:
- Examine current treatment options in rheumatoid arthritis (RA) and steps to address and/or minimize treatment failure
- Identify emerging treatment pathways in RA and associated pathways
- Explain the requirements necessary for a biosimilar agent to be approved for use
- Illustrate methods to improve care for patients with RA
Target audience: Pharmacists
Type of activity: Application
Release date: June 15, 2017
Expiration date: June 15, 2018
Estimated time to complete activity: 2.0 hours
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-059-H01-P. The activity is available for CE credit through June 15, 2018.